UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Thirty percent of adult patients with primary refractory Hodgkin's disease (HD) are progression free at 5 years after high dose therapy (HDT) and autologous stem cell transplantation (ASCT): Data from 290 patients reported to the EBMT.

Sweetenham, JW; Taghipour, G; Linch, DC; Goldstone, AH; (1996) Thirty percent of adult patients with primary refractory Hodgkin's disease (HD) are progression free at 5 years after high dose therapy (HDT) and autologous stem cell transplantation (ASCT): Data from 290 patients reported to the EBMT. BLOOD , 88 (10) 1932 - 1932.

Full text not available from this repository.
Type: Article
Title: Thirty percent of adult patients with primary refractory Hodgkin's disease (HD) are progression free at 5 years after high dose therapy (HDT) and autologous stem cell transplantation (ASCT): Data from 290 patients reported to the EBMT.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/1308189
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item